JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harakal, C.
Right arrow Articles by Rusy, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harakal, C.
Right arrow Articles by Rusy, B. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 144, Issue 1, 89-96, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


HEMODYNAMIC EFFECTS OF TYRAMINE

Concetta Harakal 1, Roger W. Sevy 1, and Ben F. Rusy 1

1 Departments of Pharmacology and Anesthesiology, Temple University School of Medicine, Philadelphia, Pennsylvania

The aim of this study was to provide a clearer definition of the cardiovascular actions of tyramine in intact conscious as well as anesthetized dogs, and where possible to localize the major cardiovascular sites of action. In pentobarbitalized open-chest dogs, pressor doses of tyramine HCl i.v. increased heart rate, cardiac output and force of myocardial contraction. Total peripheral resistance first increased, but then decreased despite the persistence of a pressor response. In unanesthetized trained dogs, using the rate of rise (first derivative) of left ventricular pressure as an index of myocardial contractile response, the responses to tyramine were similar except that heart rate decreased. In addition, the pattern of response with respect to cardiac output and total peripheral resistance was not the same in all animals. During the latter part of the pnesson response, cardiac output was the major determinate of pressure in the majority of animals. Local vasoconstrictor and positive inotropic cardiac effects of tyramine were demonstrated by regional i.a. injections of subpressor doses in anesthetized dogs: pressure/flow ratios increased in renal, mesentenic and femoral vascular beds when minimal doses were injected, respectively, into the renal, superior mesenteric and femoral artery; the force of left ventricular contraction increased when minimal doses were injected into the circumflex branch of the left coronary artery. The hypothesis that tyramine acts indirectly via catecholamine release is supported by the findings that local (renal) vasoconstrictor responses, myocardial contractile responses and pressor responses were reduced by reserpine pretreatment. The results in both anesthetized and unanesthetized animals indicate that both cardiac and vasoconstrictor responses to tyramine must be taken into account whenever the pressor effect is used in analyzing the actions of tyramine and the modification of its action by other drugs.

Submitted on October 16, 1963
Accepted on November 27, 1963







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.